Noxopharm Appoints New Chair
10 September 2020 Release date 9 September 2020 Australian clinical-stage drug development company Noxopharm Limited (ASX:NOX) announces the appointment of Mr Fred Bart as Non-Executive Chair, allowing ExecutiveChair and CEO, Dr Graham Kelly, to focus on the CEO…
Global CRO To Execute Noxopharm DARRT-2 Prostate Cancer Study
10 September 2020 Release date 8 September 2020 Australian clinical-stage drug development company Noxopharm Limited (ASX:NOX) is pleased to announce that after a rigorous global search, the clinical research organisation (CRO), Parexel® Biotech, has been appointed to manage…
Allens: Capturing the hydrogen opportunity for Australia and Japan
10 September 2020 Now is the time to look for future global opportunities Australia’s hydrogen industry is expected to contribute at least $11 billion to the national economy and generate around 7,600 jobs by 2050. In the current state of play,…
New drug shown to improve bone growth in children with achondroplasia in global phase III trial
10 September 2020 Release date 4 September 2020 A phase three global clinical trial led by the Murdoch Children’s Research Institute (MCRI) has shown a new drug boosts bone growth in children born with achondroplasia, the most common type of…
New AusBiotech industry Advisory Group Chairs appointed
10 September 2020 Release date 3 September 2020 AusBiotech welcomes its new industry Advisory Group Chairs: Dr Megan Robertson, St Vincent’s Hospital Melbourne, Chair of the AusBiotech Clinical Trials Adivsory Group; and Dr Amanda Gillon, Bioscience Managers, Chair…
Cynata Cymerus MSCs Demonstrate Efficacy in Preclinical Lung Disease Study
7 September 2020 Cynata Therapeutics Limited (ASX: “CYP”, “Cynata”, or the “Company”), a clinical-stage biotechnology company specialising in cell therapeutics, has today announced positive efficacy data from a study of its induced pluripotent stem cell (iPSC)-derived Cymerus™ mesenchymal…
Victorian Government Grant for PolyNovo Hernia Plant
7 September 2020 PolyNovo is pleased to announce it has received a grant from the Victorian Government, Department of Jobs, Innovation and Trade for up to $252,000. This funding is to support the purchase of equipment and the…
CSL to manufacture and supply University of Queensland and Oxford University vaccine candidates for Australia
7 September 2020 Heads of Agreement signed between CSL and the Australian Government to supply 51 million doses of University of Queensland vaccine to Australia, with first doses scheduled for release from mid-2021 following successful clinical trials. Heads…
Snoretox receives “Barrier to Innovation” Waiver from FDA (Center for Veterinary Medicine) for Innovative Medical Breakthrough Therapy.
Date Posted: 7 September 2020 4 September 2020 Drug Solution for Hypotonic Muscle Disorders. Snoretox receives “Barrier to Innovation” Waiver from FDA (Center for Veterinary Medicine) for Innovative Medical Breakthrough Therapy. Snoretox Pty Ltd has invented and patented…
$4.1 million raised in fully allocated AdAlta Entitlement Offer
7 September 2020 Highlights $4.1 million raised in fully allocated Entitlement Offer Total of $8.1 million raised across Placement and Entitlement Offer Majority of funds from existing shareholders Provides funds to progress growth strategy through 2021, adding value…
$0.75M Funding Awarded to LBT Innovations For APAS®-AMR Analysis Module
3 September 2020 Australian medical technology company LBT Innovations Limited (ASX: LBT) (LBT or the Company), a leader in medical technology automation using artificial intelligence, is pleased to announce the Company has been awarded funding under MTPConnect’s Biomedical…
The answer to self-discovery is found at Cartherics
3 September 2020 Originally posted by Catherics. For new recruit Walid Azar, it was about finding his calling. As Walid Azar settles into his new dual role as Senior Research Fellow and Deputy Lab Manager at Cartherics, he…
